ITGB1 and non-small cell lung carcinoma: To investigate the biological roles of miR-493-5p and ITGB1 in NSCLC progression, we performed loss-of-function studies using a miR-493-5p inhibitor and siITGB1 on the NSCLC cell line A549 (Figure 5A).